These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A herbal formula, SYKT, reverses doxorubicin‑induced myelosuppression and cardiotoxicity by inhibiting ROS‑mediated apoptosis. Chen T, Shen HM, Deng ZY, Yang ZZ, Zhao RL, Wang L, Feng ZP, Liu C, Li WH, Liu ZJ. Mol Med Rep; 2017 Apr; 15(4):2057-2066. PubMed ID: 28260045 [Abstract] [Full Text] [Related]
25. Protective effect of naringenin-7-O-glucoside against oxidative stress induced by doxorubicin in H9c2 cardiomyocytes. Han XZ, Gao S, Cheng YN, Sun YZ, Liu W, Tang LL, Ren DM. Biosci Trends; 2012 Feb; 6(1):19-25. PubMed ID: 22426099 [Abstract] [Full Text] [Related]
29. Transcriptional activation of ENPP2 by FoxO4 protects cardiomyocytes from doxorubicin‑induced toxicity. He L, Yang Y, Chen J, Zou P, Li J. Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34296293 [Abstract] [Full Text] [Related]
31. All-trans retinoic acid protects against doxorubicin-induced cardiotoxicity by activating the ERK2 signalling pathway. Yang L, Luo C, Chen C, Wang X, Shi W, Liu J. Br J Pharmacol; 2016 Jan; 173(2):357-71. PubMed ID: 26507774 [Abstract] [Full Text] [Related]
32. Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin. Li K, Sung RY, Huang WZ, Yang M, Pong NH, Lee SM, Chan WY, Zhao H, To MY, Fok TF, Li CK, Wong YO, Ng PC. Circulation; 2006 May 09; 113(18):2211-20. PubMed ID: 16651473 [Abstract] [Full Text] [Related]
33. Resveratrol suppresses doxorubicin-induced cardiotoxicity by disrupting E2F1 mediated autophagy inhibition and apoptosis promotion. Gu J, Fan YQ, Zhang HL, Pan JA, Yu JY, Zhang JF, Wang CQ. Biochem Pharmacol; 2018 Apr 09; 150():202-213. PubMed ID: 29475062 [Abstract] [Full Text] [Related]
34. Protective effects of deep sea water against doxorubicin‑induced cardiotoxicity in H9c2 cardiac muscle cells. Lee DH, Kim S, Nam KS. Int J Oncol; 2014 Dec 09; 45(6):2569-75. PubMed ID: 25270851 [Abstract] [Full Text] [Related]
35. Cinnamic Acid Derivatives as Cardioprotective Agents against Oxidative and Structural Damage Induced by Doxorubicin. Koczurkiewicz-Adamczyk P, Klaś K, Gunia-Krzyżak A, Piska K, Andrysiak K, Stępniewski J, Lasota S, Wójcik-Pszczoła K, Dulak J, Madeja Z, Pękala E. Int J Mol Sci; 2021 Jun 09; 22(12):. PubMed ID: 34207549 [Abstract] [Full Text] [Related]
36. The mRNA expression of Il6 and Pdcd1 are predictive and protective factors for doxorubicin‑induced cardiotoxicity. Kanno SI, Hara A. Mol Med Rep; 2021 Feb 09; 23(2):. PubMed ID: 33300057 [Abstract] [Full Text] [Related]
37. AP39, a novel mitochondria-targeted hydrogen sulfide donor ameliorates doxorubicin-induced cardiotoxicity by regulating the AMPK/UCP2 pathway. Zhang B, Li Y, Liu N, Liu B. PLoS One; 2024 Feb 09; 19(4):e0300261. PubMed ID: 38568919 [Abstract] [Full Text] [Related]
38. Ginkgolide B Exerts Cardioprotective Properties against Doxorubicin-Induced Cardiotoxicity by Regulating Reactive Oxygen Species, Akt and Calcium Signaling Pathways In Vitro and In Vivo. Gao J, Chen T, Zhao D, Zheng J, Liu Z. PLoS One; 2016 Feb 09; 11(12):e0168219. PubMed ID: 27973574 [Abstract] [Full Text] [Related]
40. Galectin-3 inhibition attenuates doxorubicin-induced cardiac dysfunction by upregulating the expression of peroxiredoxin-4. Tian Y, Lv W, Lu C, Jiang Y, Yang X, Song M. Can J Physiol Pharmacol; 2020 Oct 09; 98(10):700-707. PubMed ID: 32516552 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]